$86.35
0.770.90%
Ultimo aggiornamento: 2:14 PM
Comments
Loading...
Guidance e previsioni
Edwards Lifesciences fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.56 | $2.62 | $2.51 | $5.93B | $6.10B | $5.98B | |
10/30/2025 | EW | Edwards Lifesciences | Q4 | 2025 | $0.58 | $0.64 | $0.59 | $1.51B | $1.59B | $1.50B | |
08/06/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.45 | $2.55 | $2.49 | — | — | — | |
07/24/2025 | EW | Edwards Lifesciences | Q3 | 2025 | $0.54 | $0.60 | $0.62 | $1.46B | $1.54B | $1.49B | |
07/24/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.90B | $6.10B | $5.90B | |
04/23/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.70B | $6.10B | $5.82B | |
04/23/2025 | EW | Edwards Lifesciences | Q2 | 2025 | $0.59 | $0.65 | $0.62 | $1.45B | $1.53B | $1.46B | |
02/11/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.60B | $6.00B | $5.84B | |
02/11/2025 | EW | Edwards Lifesciences | Q1 | 2025 | $0.58 | $0.64 | $0.59 | $1.35B | $1.43B | $1.42B | |
12/04/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $5.83B | |
12/04/2024 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.60B | $6.00B | $5.92B | |
10/24/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $6.13B | |
10/24/2024 | EW | Edwards Lifesciences | Q4 | 2024 | $0.53 | $0.57 | $0.62 | $1.33B | $1.39B | $1.44B | |
07/24/2024 | EW | Edwards Lifesciences | Q3 | 2024 | $0.67 | $0.71 | $0.69 | $1.56B | $1.64B | $1.62B | |
04/25/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.75 | $6.60B | $6.60B | $6.52B | |
04/25/2024 | EW | Edwards Lifesciences | Q2 | 2024 | $0.67 | $0.71 | $0.70 | $1.62B | $1.70B | $1.64B | |
02/06/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.76 | $6.30B | $6.60B | $6.48B | |
02/06/2024 | EW | Edwards Lifesciences | Q1 | 2024 | $0.62 | $0.66 | $0.66 | $1.53B | $1.61B | $1.56B | |
12/07/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.47 | $2.53 | $2.51 | $5.90B | $6.10B | $5.97B | |
12/07/2023 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.80 | $6.30B | $6.60B | $6.51B | |
10/25/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.92B | $6.08B | $6.00B | |
10/25/2023 | EW | Edwards Lifesciences | Q4 | 2023 | $0.60 | $0.66 | $0.68 | $1.45B | $1.53B | $1.54B | |
07/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.90B | $6.10B | $5.96B | |
07/26/2023 | EW | Edwards Lifesciences | Q3 | 2023 | $0.55 | $0.61 | $0.63 | $1.44B | $1.52B | $1.47B | |
04/26/2023 | EW | Edwards Lifesciences | Q2 | 2023 | $0.62 | $0.68 | $0.63 | $1.48B | $1.56B | $1.46B | |
04/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.48 | $2.60 | $2.52 | $6.00B | $6.00B | $5.85B | |
01/31/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.50 | $5.60B | $6.00B | $5.78B | |
01/31/2023 | EW | Edwards Lifesciences | Q1 | 2023 | $0.58 | $0.64 | $0.59 | $1.37B | $1.45B | $1.37B | |
12/08/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.45 | $5.35B | $5.35B | $5.36B | |
12/08/2022 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.52 | $5.60B | $6.00B | $5.71B | |
10/27/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.51 | $5.35B | $5.35B | $5.47B | |
07/28/2022 | EW | Edwards Lifesciences | Q3 | 2022 | $0.58 | $0.66 | $0.65 | $1.30B | $1.37B | $1.44B | |
07/28/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.50 | $2.56 | $5.35B | $5.55B | $5.71B | |
04/26/2022 | EW | Edwards Lifesciences | Q2 | 2022 | $0.61 | $0.69 | $0.65 | $1.36B | $1.44B | $1.46B | |
04/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.55 | $5.50B | $6.00B | $5.76B | |
01/26/2022 | EW | Edwards Lifesciences | Q1 | 2022 | $0.54 | $0.62 | $0.60 | $1.27B | $1.35B | $1.36B | |
01/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.82B | |
12/08/2021 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.85B |
FAQ
Qual è la guidance più recente per Edwards Lifesciences (EW)?
Le ultime previsioni per Edwards Lifesciences (EW) sono state riportate il ottobre 30, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $2.56 a $2.62, rispetto all'EPS stimato di $2.51. Inoltre, Edwards Lifesciences ha previsto ricavi tra $5.93B e $6.10B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.